Siga Technologies (SIGA) Change in Receivables (2010 - 2025)
Siga Technologies (SIGA) reported Change in Receivables of -$4.0 million for Q3 2025, down 227.49% on a YoY basis from $3.1 million in Q3 2024, and down 471.61% quarter-over-quarter from -$699108.0 in Q2 2025.
Siga Technologies (SIGA) Change in Receivables (2010 - 2025) Analysis & Trends
Siga Technologies has reported Change in Receivables for 16 years, with the latest figure at -$4.0 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Receivables fell 227.49% year-over-year to -$4.0 million; the trailing twelve-month figure through Sep 2025 stood at -$9.6 million (down 337.66% YoY), and the FY2024 full-year result was $35178.0, up 100.14% from the prior year.
- Change in Receivables for Q3 2025 stood at -$4.0 million, down from -$699108.0 in the prior quarter.
- The five-year high for Change in Receivables was $79.8 million in Q4 2021, with the low at -$78.3 million in Q1 2022.
- Historically, Change in Receivables has averaged -$44738.4 across 5 years, with a median of -$699108.0 in 2025.
- The largest YoY upside for Change in Receivables was 1144.17% in 2022 against a maximum downside of 11947.51% in 2022.
- Siga Technologies' Change in Receivables stood at $79.8 million in 2021, then sank by 111.92% to -$9.5 million in 2022, then jumped by 237.42% to $13.1 million in 2023, then slumped by 30.61% to $9.1 million in 2024, then plunged by 144.02% to -$4.0 million in 2025.
- The last three Change in Receivables figures came in at -$4.0 million (Q3 2025), -$699108.0 (Q2 2025), and -$14.0 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.23 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 116.25 Mn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.00 Mn |
| Sep 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -699,108.00 |
| Jun 30, 2025 | -699,108.00 |
| Mar 31, 2025 | -13.98 Mn |
| Mar 31, 2025 | -13.98 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | -9.17 Mn |
| Jun 30, 2024 | -9.17 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | -6.29 Mn |
| Jun 30, 2023 | -6.29 Mn |